CSIMarket Company Name, Ticker, Suppliers, else..
 
Atrium Therapeutics Inc   (NASDAQ: RNA)
 
Price: $13.7700 $0.45 3.378%
Day's High: $13.920000076293945 Week Perf: -0.58 %
Day's Low: $ 13.20 30 Day Perf: 21.54 %
Volume (M): 178,348 52 Wk High: $ 73.06
Volume (M$): $ 0 52 Wk Avg: $37.24
Open: $13.39 52 Wk Low: $11.13



 Market Capitalization (Millions $) 236
 Shares Outstanding (Millions) 17
 Employees 511
 Revenues (TTM) (Millions $) 37
 Net Income (TTM) (Millions $) -680
 Cash Flow (TTM) (Millions $) 503
 Capital Exp. (TTM) (Millions $) 12

Business Description


Avidity Biosciences Inc is a biotechnology company focused on the development of antibody-based therapeutics. Using its proprietary AOC technology, the company aims to create novel therapies that can address a wide range of diseases, including cancer, autoimmune disorders, and genetic diseases. Avidity Biosciences combines the high specificity of antibodies with the precision of small molecules to deliver therapeutics that can efficiently target specific cells or tissues. By leveraging its innovative platform, the company aims to revolutionize the treatment of various diseases and improve patient outcomes.


   Company Address: 10578 Science Center Drive San Diego 92121 CA
   Company Phone Number: 876-0700   Stock Exchange / Ticker: NASDAQ RNA


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ALNY        2.51% 
ARWR   -6.91%    
PFE   -0.07%    
REGN   -1.17%    
SRPT        12.74% 
VRTX   -0.94%    
• View Complete Report
   



Stocks on the Move

Avidity Biosciences Inc Assessing the Factors Behind Recent Stock Fluctuations and Future Potential

Published Tue, Jul 9 2024 10:23 AM UTC

Avidity Biosciences Inc, a biopharmaceutical company focused on developing RNA-based therapies, has experienced mixed performance in its stock value this year. While some instances have seen a decline, key breakthroughs and positive evaluations have also caused the stock to surge. In this article, we will explore the reasons behind Avidity Biosciences stock fluctuations and...
Stocks on the Move

Avidity Biosciences Harnesses RNA Therapeutics to Transform Biopharmaceutical Landscape

Published Fri, Jun 28 2024 2:08 PM UTC

In recent news, Avidity Biosciences, a pioneering biopharmaceutical company, has made significant strides in its mission to revolutionize the treatment landscape through its innovative RNA therapeutics platform. Avidity Biosciences is committed to developing Antibody Oligonucleotide Conjugates (AOCstm), a novel class of therapeutics that hold immense potential in targeting d...
Stocks on the Move

Avidity Biosciences Inc. Growing Momentum in Biopharmaceutical Innovation

Published Thu, Jun 27 2024 10:15 AM UTC

In recent weeks, Avidity Biosciences Inc. (NASDAQ: RNA) has made significant headway in the biopharmaceutical industry, positioning itself as a leader in the field of RNA therapeutics. The company s commitment to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs) has garnered attention from investors and industry experts alike. With ...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 6.40
Price to Sales (Expected) -
Price to Book 1.01
PEG (TTM) -

Financial Strength Current
Quick Ratio 12.23
Working Capital Ratio 13.04
Leverage Ratio (MRQ) 0.25
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -5.17 $
Revenues (TTM) 2.15 $
Cash Flow (TTM) 29.4 $
Cash 15.66 $
Book Value 13.69 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 72,049
Net Income per Employee (TTM) -1,329,814
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.03

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -88.01 %
Net Margin (MRQ) -84.71 %
Net Cash Flow Margin (MRQ) 1366.25 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Atrium Therapeutics Inc's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.